ESPR Net Income Growth
Esperion Therapeutics Inc · Net Income Growth
ESPR Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported37.72%period ending
ESPR Quarterly Net Income YoY % (-27.44% → 37.72%)
Year-over-year change
High-resolution chart · PNG
ESPR net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 37.7185% | |
| 390.0413% | |
| -6.1272% | |
| 79.4509% | |
| -166.2958% | |
| 62.1646% | |
| 28.4267% | |
| -24.0112% | |
| 198.8707% | |
| -1.5445% | |
| 25.1592% | |
| 24.7105% | |
| -8.7924% | |
| 14.7914% | |
| 20.5647% | |
| -51.8824% | |
| 37.6137% | |
| 37.6709% | |
| 18.7869% | |
| -135.0435% | |
| -16.2123% | |
| -68.6566% | |
| -24.9499% | |
| 329.8205% | |
| -189.5513% | |
| -3.1763% | |
| -36.9979% | |
| -18.5677% | |
| 289.419% | |
| -58.4519% | |
| -10.3762% | |
| -5.5218% | |
| -13.786% | |
| -30.8572% | |
| -159.8494% | |
| -208.7781% | |
| -177.9637% | |
| -120.6676% | |
| -35.9425% | |
| -13.2311% | |
| -27.2022% | |
| -38.7544% | |
| -30.5425% | |
| -34.1741% | |
| -45.6185% | |
| 2.399% | |
| -87.1933% | |
| -33.4764% | |
| -85.7436% | |
| -249.1244% | |
| -56.3117% | |
| -118.5957% | |
| -73.1017% | |
| 5.9742% | |
| -7.8093% | |
| -1.4104% | |
| -4.3348% | |
| -11.1288% | |
| -23.6996% | |
| -22.1033% | |
| -13.9982% | |
| 41.8641% | |
| 2.9014% | |
| -27.441% |